These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). Hubner KF; McDonald TW; Niethammer JG; Smith GT; Gould HR; Buonocore E Gynecol Oncol; 1993 Nov; 51(2):197-204. PubMed ID: 8276294 [TBL] [Abstract][Full Text] [Related]
18. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465 [TBL] [Abstract][Full Text] [Related]
19. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. Laubenbacher C; Saumweber D; Wagner-Manslau C; Kau RJ; Herz M; Avril N; Ziegler S; Kruschke C; Arnold W; Schwaiger M J Nucl Med; 1995 Oct; 36(10):1747-57. PubMed ID: 7562038 [TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]